Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 401–500 of 1,004
SORCS1: A Novel Human Type 2 Diabetes Susceptibility Gene Suggested by the Mouse
Goodarzi, M. O., Lehman, D. M., Taylor, K. D., Guo, X., Cui, J., Quiñones, M. J., Clee, S. M., Yandell, B. S., Blangero, J., Hsueh, W. A., et al. (2007) · Diabetes · doi:10.2337/db06-1677 · Cited by 93
“This approach led to the discovery of calpain-10 (CAPN10) and TCF7L2 as genes that contribute to diabetes risk (6,7).”
BackgroundTCF7L2 genetic defect and type 2 diabetes
Cauchi, S., & Froguel, P. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0026-x · Cited by 97
Palmer, N. D., Hester, J. M., An, S. S., Adeyemo, A., Rotimi, C. N., Langefeld, C. D., Freedman, B. I., Ng, M. C. Y., & Bowden, D. W. (2010) · Diabetes · doi:10.2337/db10-0134 · Cited by 92
“In addition, the previously associated (21) microsatellite marker DG10S478, which lies 38 kb distal to and outside of this LD block, was typed, and the results of the analysis are”
BackgroundResultInfluentialKimber, C. H., Doney, A. S. F., Pearson, E. R., McCarthy, M. I., Hattersley, A. T., Leese, G., Morris, A. D., & Palmer, C. N. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0661-9 · Cited by 88
“Intensive single-nucleotide polymorphism (SNP) analysis and resequencing revealed that TCF7L2 gene variants, including microsatellite DG10S478, SNP rs12255372 and rs7903146, are in tight linkage disequilibrium and were associated with type 2 diabetes [3].”
A computational system to select candidate genes for complex human traits
Gaulton, K. J., Mohlke, K. L., & Vision, T. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm001 · Cited by 105
TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women
Cornelis, M. C., Qi, L., Kraft, P. L., & Hu, F. B. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27058 · Cited by 99
“TCF7L2 is the strongest locus associated with T2D identified thus far (4, 5).”
BackgroundEffect of genetic and environmental influences on cardiometabolic risk factors: a twin study
Jermendy, G., Horváth, T., Littvay, L., Steinbach, R., Jermendy, Á. L., Tárnoki, Á. D., Tárnoki, D. L., Métneki, J., & Osztovits, J. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-96 · Cited by 96
“This was the case for type 2 diabetes and the metabolic syndrome [36-38] but functional gene variants were observed also in hypertension [39] and in lipid abnormalities [40].”
Genes, Diet and Type 2 Diabetes Mellitus: A Review
Dedoussis, G. V. Z., Kaliora, A. C., & Panagiotakos, D. B. (2007) · The Review of Diabetic Studies · doi:10.1900/rds.2007.4.13 · Cited by 86
“[29] have identified TCF7L2 as a novel susceptibility gene for T2DM and reported an association with the microsatellite marker DG10S478 within intron 3.”
BackgroundMusso, G., Gambino, R., Pacini, G., Pagano, G., Durazzo, M., & Cassader, M. (2009) · Hepatology · doi:10.1002/hep.22659 · Cited by 87
Lin, Y., Li, P., Cai, L., Zhang, B., Tang, X., Zhang, X., Li, Y., Xian, Y., Yang, Y., Wang, L., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-97 · Cited by 90
“The TCF7L2 gene, initially mapped by a linkage study, is the strongest known T2D association gene in European original populations [9].”
Environmental Biology and Human Disease
Schwartz, D., & Collins, F. (2007) · Science · doi:10.1126/science.1141331 · Cited by 86
Systematic Review of Polygenic Risk Scores for Type 1 and Type 2 Diabetes
Padilla-Martínez, F., Collin, F., Kwaśniewski, M., & Kretowski, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051703 · Cited by 106
Weedon, M. N. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02258.x · Cited by 87
Haupt, A., Thamer, C., Heni, M., Ketterer, C., Machann, J., Schick, F., Machicao, F. E., Stefan, N., Claussen, C. D., Häring, H., et al. (2009) · Diabetes · doi:10.2337/db09-1050 · Cited by 86
“Diabetes 59:747–750, 2010 Variation in the transcription factor 7-like two (TCF7L2) gene strongly determines the risk of type 2 diabetes (1) mainly via what is believed to be its effects on -cell function, and the insulin secretion deficit of carriers of the diabetes risk alleles (2) may be explained at least in part…”
BackgroundPeng, S., Zhu, Y., Lü, B., Xu, F., Li, X., & Lai, M. (2012) · Mutagenesis · doi:10.1093/mutage/ges048 · Cited by 99
“Finally, we obtained 48 articles for inclusion in this meta-analysis: 44 articles, including 60 studies on rs7903146 (4,5,12,13,15,18,19,29–65); 31 articles, including 40 studies on rs12255372 (4,12,13,18,19,29,31,33–45,47– 53,55,57,65,66); 12 articles, including 18 studies on rs11196205 (12,13,17,18,30,34,36,39,47–49…”
BackgroundPappa, K. I., Gazouli, M., Economou, K., Daskalakis, G., Anastasiou, E., Anagnou, N. P., & Antsaklis, A. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.490609 · Cited by 85
“41 respectively to progress from impaired glucose tolerance to T2D [23].”
BackgroundMechanisms of Disease: the genetic basis of coronary heart disease
Kullo, I. J., & Ding, K. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0982 · Cited by 95
“(interleukin-2 receptor alpha chain) have been associated with type 1 diabetes mellitus; polymorphisms in TCF7L2”
BackgroundLiu, Y., Zhou, D., Zhang, D., Chen, Z., Zhao, T., Zhang, Z., Ning, M., Hu, X., Yang, Y., Zhang, Z., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1375-y · Cited by 87
“PPARG, KCNJ11 and TCF7L2 [2–4].”
Wirström, T., Hilding, A., Gu, H. F., Östenson, C., & Björklund, A. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.045583 · Cited by 102
“The TCF7L2 gene is a major susceptibility locus for T2D (12, 13).”
Backgrounddel Río-Moreno, M., Alors‐Pérez, E., González‐Rubio, S., Ferrín, G., Reyes, Ó., Rodríguez‐Perálvarez, M., Sánchez‐Frías, M., Sánchez‐Sánchez, R., Ventura, S., López‐Miranda, J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00021 · Cited by 93
Beta cell dysfunction in diabetes: the islet microenvironment as an unusual suspect
Almaça, J., Caicedo, A., & Landsman, L. (2020) · Diabetologia · doi:10.1007/s00125-020-05186-5 · Cited by 93
Revisiting the Thrifty Gene Hypothesis via 65 Loci Associated with Susceptibility to Type 2 Diabetes
Ayub, Q., Moutsianas, L., Chen, Y., Panoutsopoulou, K., Colonna, V., Pagani, L., Prokopenko, I., Ritchie, G. R. S., Tyler‐Smith, C., McCarthy, M. I., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.12.010 · Cited by 99
Pharmacogenetics of metformin response: a step in the path toward personalized medicine
Reitman, M. L., & Schadt, E. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32133 · Cited by 85
Ciccacci, C., Fusco, D. D., Cacciotti, L., Morganti, R., D’Amato, C., Novelli, G., Sangiuolo, F. C., Spallone, V., & Borgiani, P. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0418-x · Cited by 92
“The results of the case–control association study (Table 2) are well in line with the numerous studies showing that TCF7L2 variants are associated with T2DM [2, 3, 22, 23] and influence the risk of diabetes via pancreatic beta cell dysfunction [24].”
ResultCDKAL1 and type 2 diabetes: a global meta-analysis
Dehwah, M. A. S., Wang, M., & Huang, Q. (2010) · Genetics and Molecular Research · doi:10.4238/vol9-2gmr802 · Cited by 85
Zhong Chong, Z., Hou, J., Chen Shang, Y., Wang, S., & Maiese, K. (2011) · Current Neurovascular Research · doi:10.2174/156720211795495402 · Cited by 83
“Variations in genes in the Wnt signaling pathway, such as transcription factor 7-like 2 gene, may impart increased risk for type 2 DM in some populations [30].”
BackgroundFan, B., Lkhagvadorj, S., Cai, W., Young, J. M., Smith, R. M., Dekkers, J. C. M., Huff-Lonergan, E. J., Lonergan, S. M., & Rothschild, M. F. (2009) · Meat Science · doi:10.1016/j.meatsci.2009.10.025 · Cited by 103
“FTO and TCF7L2 have been identified as the most promising candidates associated with type II diabetes (T2D) in humans (Dina et al., 2007; Frayling et al., 2007; Grant et al., 2006).”
BackgroundHuman Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future
Ingelsson, E., & McCarthy, M. I. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.118.002090 · Cited by 81
The Genetics of Pediatric Obesity
Chesi, A., & Grant, S. F. A. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.08.008 · Cited by 106
“For instance, the T2D locus TCF7L2 [83] has been refined utilizing a West African cohort [84].”
BackgroundSelf-citationOh, K.-J., Park, J., Kim, S. S., Oh, H., Choi, C. S., & Koo, S.-H. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002986 · Cited by 83
“Extensive genome-wide association (GWA) studies revealed that TCF7L2 is a strong candidate for a type 2 diabetes gene, and several studies indicated that the presence of certain common single nucleotide polymorphisms (SNPs) in this gene might increase the incidence of this disease in human [28,29,30,31,32,33,34,35].”
BackgroundCatchpole, B., Adams, J. P., Holder, A. L., Short, A. D., Ollier, W., & Kennedy, L. J. (2012) · The Veterinary Journal · doi:10.1016/j.tvjl.2012.11.013 · Cited by 100
The Spectrum of MYH9-Associated Nephropathy
Bostrom, M. A., & Freedman, B. I. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08721209 · Cited by 89
“The strongest and most replicated diabetes genes, such as TCF7L2, contribute approximately a 40% increase in risk for each risk variant that is inherited (34).”
BackgroundCommon Variants in Maturity-Onset Diabetes of the Young Genes and Future Risk of Type 2 Diabetes
Holmkvist, J., Almgren, P., Lyssenko, V., Lindgren, C. M., Eriksson, K.-F., Isomaa, B., Tuomi, T., Nilsson, P., & Groop, L. (2008) · Diabetes · doi:10.2337/db06-1464 · Cited by 83
Susceptibility genes in Graves’ ophthalmopathy: searching for a needle in a haystack?
Bednarczuk, T., Gopinath, B., Ploski, R., & Wall, J. R. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02854.x · Cited by 82
Microarray Technology and Applications in the Arena of Genome-Wide Association
Grant, S. F. A., & Hakonarson, H. H. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105395 · Cited by 92
“From the first batch of such studies, recently published in Nature (15, 16) and Science (17–19), the strongest associationbyfaroftheapproximately20establishedloci was with a gene established in 2006 by Grant et al.( 20 ) in Nature Genetics as playing a role in the disease, namely the Wnt-signaling pathway member, TCF7…”
BackgroundSelf-citationWnt signaling preserves progenitor cell multipotency during adipose tissue development
Yang, Z., Joyce, S., DeSouza, T., Solivan-Rivera, J., Desai, A., Skritakis, P., Yang, Q., Ziegler, R., Zhong, D., Nguyen, T., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00813-y · Cited by 88
Norman, P. E., Davis, T. M. E., Le, M., & Golledge, J. (2007) · Connective Tissue Research · doi:10.1080/03008200701331524 · Cited by 82
“A number of genetic polymorphisms have now been linked with the development of diabetic complications [44, 45].”
BackgroundThe in vitro and in vivo effects of yerba mate (Ilex paraguariensis) extract on adipogenesis
Arçari, D. P., Santos, J. C., Gambero, A., & Ribeiro, M. L. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.04.062 · Cited by 94
Genetic Variation in KCNQ1 Associates With Fasting Glucose andβ-Cell Function
Tan, J. T., Nurbaya, S., Gardner, D., Ye, S., Tai, E. S., & Ng, D. P. K. (2009) · Diabetes · doi:10.2337/db08-1138 · Cited by 82
“Single-nucleotide polymorphism (SNP) analysis of genome variation in large cohorts have led to the identification of several genes being implicated in the pathogenesis of type 2 diabetes, of which TCF7L2 has been considered to be the most important to date (5).”
BackgroundGene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate
Ortega, Á., Berná, G., Rojas, A., Martín, F., & Soria, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061188 · Cited by 96
“One of the most important is the TCF7L2 gene encoding the transcription factor TCF7-like 2 located on chromosome 10 [198].”
BackgroundWang, X., Strizich, G., Hu, Y., Wang, T., Kaplan, R. C., & Qi, Q. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12323 · Cited by 81
“Subsequently, transcription factor 7-like 2 (T-cell specific, HMG-box) (TCF7L2) became the first T2D-associated gene uncovered by a large-scale association analysis (n = 3774).(12) Wolfram syndrome 1 (wolframin) (WFS1), involved in pancreatic β-cell function and survival, was reported to be associated with T2D on the…”
BackgroundEzzidi, I., Mtiraoui, N., Cauchi, S., Vaillant, E., Dechaume, A., Chaieb, M., Kacem, M., Almawi, W. Y., Froguel, P., Mahjoub, T., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-33 · Cited by 86
“The SNP with the largest risk effect is the intronic variant, rs7903146, in the TCF7L2 locus [13,14].”
BackgroundResultThe Wnt signaling pathway and rheumatoid arthritis
Rabelo, F. D. S., da Mota, L. M. H., Lima, R. A. C., Lima, F. A. C., Barra, G. B., de Carvalho, J. F., & Amato, A. A. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.08.003 · Cited by 84
“found the T allele of the TCF7L2 gene polymorphism rs7903146 to be correlated with type 2 diabetes in Denmark, the USA and Iceland [29,30].”
BackgroundOwen, K. R., & McCarthy, M. I. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.04.003 · Cited by 101
TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes
Holstein, A., Hahn, M., Körner, A., Stümvoll, M., & Kovacs, P. L. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-30 · Cited by 82
“Variants in the TCF7L2 have initially been shown to be associated with an increased risk for type 2 diabetes (T2D) in a genome-wide analysis of the isolate population of Iceland [2].”
Machiela, M. J., Lindström, S., Allen, N. E., Haiman, C. A., Albanes, D., Barricarte, A., Berndt, S. I., Bueno-de-Mesquita, H. B., Chanock, S. J., Gaziano, J. M., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws191 · Cited by 86
Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants
Mohlke, K. L., Boehnke, M., & Abecasis, G. R. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn275 · Cited by 95
“common type 2 diabetes (T2D)-associated variants within transcription factor 7-like 2 (TCF7L2) (9), a locus not previously suspected to influence T2D or related traits and which remains the most strongly associated T2D susceptibility locus to date (Table 1).”
BackgroundInfluentialThe genomic landscape of African populations in health and disease
Rotimi, C. N., Bentley, A. R., Doumatey, A. P., Chen, G., Shriner, D., & Adeyemo, A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx253 · Cited by 92
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
Nagarajan, P. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i11.1141 · Cited by 79
New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms
Schäfer, S., Machicao, F. E., Fritsche, A., Häring, H., & Kantartzis, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70008-0 · Cited by 96
Elevated Hedgehog/Gli signaling causes β-cell dedifferentiation in mice
Landsman, L., Parent, A. V., & Hebrok, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105404108 · Cited by 88
Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population
Alsmadi, O. A., Al-Rubeaan, K. A., Mohamed, G., Alkayal, F., Al‐Saud, H., Al‐Saud, N. A., Al‐Daghri, N. M., Mohammad, S., & Meyer, B. F. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-72 · Cited by 85
“More recently, researchers at Decode Genetics reported strong association between variants in a novel susceptibility gene called TCF7L2 and type 2 diabetes in Icelandic diabetic patients [8].”
BackgroundResultKamińska, D., Kuulasmaa, T., Venesmaa, S., Käkelä, P., Vaittinen, M., Pulkkinen, L., Pääkkönen, M. E., Gylling, H., Laakso, M., & Pihlajamäki, J. (2012) · Diabetes · doi:10.2337/db12-0239 · Cited by 86
“Variants in the transcription factor 7-like 2 gene (TCF7L2) increase the risk of type 2 diabetes by 30–40% (1).”
BackgroundMeta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus
Ding, W., Xu, L., Zhang, L., Han, Z., Jiang, Q., Wang, Z., & Jin, S. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0553-5 · Cited by 86
“[7] confirmed a strongly significant association between susceptibility related to T2DM and common variants in transcription factor 7-like 2 (TCF7L2) in Icelandic subjects, and the result was the same with case-control method in Danish cohort and U.”
BackgroundResultBasile, K. J., Johnson, M. E., Xia, Q., & Grant, S. F. A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/769671 · Cited by 88
“The variant found at this locus is common among the population, occurs in the noncoding region of the gene and results in an approximately 40% increase in T2D risk [31] when considered in isolation.”
BackgroundInfluentialSelf-citationSirdah, M. M., & Reading, N. S. (2020) · Clinical Genetics · doi:10.1111/cge.13772 · Cited by 89
“among different ethnicities.(161-171)Table 1 provides a list of reproducibly identified genetic risk variants linked to T2D possibly thought affecting β-cell dysfunction and reduced β-cell mass.”
BackgroundGenetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes
Jin, W., & Patti, M.-E. (2009) · Clinical Science · doi:10.1042/cs20080090 · Cited by 78
Lattanzio, S., Santilli, F., Liani, R., Vazzana, N., Ueland, T., Fulvio, P. D., Formoso, G., Consoli, A., Aukrust, P., & Davì, G. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001000 · Cited by 82
“In the past years, a growing body of evidence indicates a possible involvement of Wnt signaling in glucose metabolism and susceptibility to DM development.(32,33) Recently, an experimental study demonstrated that inhibition of the Wnt antagonist DKK-2 reduces basal blood glucose concentrations and improves glucose tol…”
BackgroundGrau, K., Cauchi, S., Holst, C., Astrup, A. V., Martínez, J. A., Saris, W. H. M., Blaak, E. E., Oppert, J., Arner, P., Rössner, S., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27947 · Cited by 79
Cohen, C. D., Lindenmeyer, M. T., Eichinger, F., Hahn, A., Seifert, M., Moll, A. G., Schmid, H., Kiss, E., Gröne, E., Gröne, H.-J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002937 · Cited by 77
“Ambiguous matches were found in TCF7 and TCF7L2, the later, a gene recently linked to the development of diabetes (but not DN) [11,12].”
Ip, W., Shao, W., Chiang, Y.-T. A., & Jin, T. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00249.2012 · Cited by 77
“During the past few years, extensive genome-wide association studies have revealed that certain single nucleotide polymorphisms (SNPs) within intronic regions of TCF7L2 are strongly associated with the risk of type 2 diabetes (9, 10).”
BackgroundMethods for Identifying Higher-Order Chromatin Structure
Sajan, S. A., & Hawkins, R. D. (2012) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090711-163818 · Cited by 77
The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes
Grant, S. F. A. (2019) · Diabetes Care · doi:10.2337/dci19-0001 · Cited by 91
“It continues to be speculated (9) that it regulates the proglucagon gene (GCG) (14), which in turn yields a posttranslational product, glucagon-like peptide 1 (GLP-1).”
BackgroundSelf-citationThe complex role of Wnt ligands in type 2 diabetes mellitus and related complications
Nie, X., Wei, X., Ma, H., Fan, L., & Chen, W. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16663 · Cited by 84
The Wnt Signaling Pathway in Diabetic Nephropathy
Wang, H., Zhang, R., Wu, X., Chen, Y., Ji, W., Wang, J., Zhang, Y., Xia, Y., Tang, Y., & Yuan, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701547 · Cited by 87
“The relationship between the Wnt signaling pathways and T2DM was first documented in 2006 (Grant et al., 2006).”
BackgroundTranscriptional regulators of hepatic gluconeogenesis
Oh, K., Han, H.-S., Kim, M.-J., & Koo, S. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0018-5 · Cited by 85
Glucose induces an autocrine activation of the Wnt/β-catenin pathway in macrophage cell lines
Anagnostou, S. H., & Shepherd, P. R. (2008) · Biochemical Journal · doi:10.1042/bj20081426 · Cited by 79
No association of multiple type 2 diabetes loci with type 1 diabetes
Raj, S. M., Howson, J. M. M., Walker, N. M., Cooper, J. D., Smyth, D. J., Field, S. F., Stevens, H. E., & Todd, J. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1391-y · Cited by 77
“37 using single nucleotide polymorphisms (SNPs) [4–16] (Table 1; ESM Tables 1 and 2).”
MethodThe what, where, when and how of Wnt/β-catenin signaling in pancreas development
Murtaugh, L. C. (2008) · Organogenesis · doi:10.4161/org.4.2.5853 · Cited by 80
Stolerman, E. S., Manning, A. K., McAteer, J. B., Fox, C. S., Dupuis, J., Meigs, J. B., & Florez, J. C. (2009) · Diabetologia · doi:10.1007/s00125-009-1266-2 · Cited by 76
“E. S. Stolerman : J. B. McAteer : J. C. Florez (*) Simches Research Building-CPZN 5.250, Diabetes Unit/Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02114, USA e-mail: jcflorez@partners.org E. S. Stolerman : J. B. McAteer : J. C. Florez Program in Medical and Population Genetics, Broad…”
BackgroundInfluentialPyMINEr Finds Gene and Autocrine-Paracrine Networks from Human Islet scRNA-Seq
Tyler, S. R., Rotti, P. G., Sun, X., Yi, Y., Xie, W., Winter, M. C., Flamme-Wiese, M. J., Tucker, B. A., Mullins, R. F., Norris, A. W., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.063 · Cited by 80
“…hormone processing and secretion, dysregulated autocrine or paracrine signaling, changes to cell identity, and/or alterations in transcriptional control of these processes (Grant et al., 2006; Khodabandehloo et al., 2016; Nicolson et al., 2009; Prentki and Nolan, 2006; Rutter et al., 2015).”
Maiese, K. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.01.009 · Cited by 76
“Abnormalities in the Wnt signaling pathways, such as with transcription factor 7-like 2 gene, may impart increased risk for type 2 DM in some populations [188–190] as well as have increased association with obesity [191].”
BackgroundThe AMP-regulated kinase family: Enigmatic targets for diabetes therapy
Rutter, G. A., & Leclerc, I. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.05.020 · Cited by 79
Kaur, K., Vig, S., Srivastava, R., Mishra, A., Singh, V. P., Srivastava, R., & Datta, M. (2015) · Diabetes · doi:10.2337/db14-1924 · Cited by 80
“Single nucleotide polymorphisms in another member of this family, TCF7L2, confer increased risk toward development of diabetes in various ethnic groups including the Indian population (26,27,32).”
Variation in TCF7L2 and Increased Risk of Colon Cancer
Folsom, A. R., Pankow, J. S., Peacock, J. M., Bielinski, S. J., HEISS, G. M., & Boerwinkle, E. (2008) · Diabetes Care · doi:10.2337/dc07-2131 · Cited by 76
“In the ARIC Study five TCF7L2 SNPs, initially reported to be associated with diabetes (rs7903146, rs12255372, r s7901695 , r s11196205 , and rs7895340) (9), were genotyped on stored DNA using the TaqMan system (Applied Biosystems, Foster City, CA).”
BackgroundMethodTCF7L2 Polymorphism Associates with New-Onset Diabetes after Transplantation
Ghisdal, L., Baron, C., Meur, Y. L., Lionet, A., Halimi, J., Rérolle, J.-P., Glowacki, F., Lebranchu, Y., Drouet, M., Noël, C., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121314 · Cited by 79
Type 2 Diabetes Susceptibility Gene TCF7L2 and Its Role in β-Cell Function
Gloyn, A. L., Braun, M., & Rorsman, P. (2009) · Diabetes · doi:10.2337/db09-0099 · Cited by 97
“There is a large number of highly correlated variants, none of which are obvious functional candidates, that show association with diabetes (5).”
BackgroundXia, Q., Chesi, A., Manduchi, E., Johnston, B., Lu, S., Leonard, M. E., Parlin, U. W., Rappaport, E. F., Huang, P., Wells, A. D., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4077-2 · Cited by 78
Self-citationMao, C. D., & Byers, S. W. (2011) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v21.i3.10 · Cited by 83
Metabolic biomarkers and gallstone disease – a population-based study
Shabanzadeh, D. M., Skaaby, T., Sørensen, L. T., Eugen-Olsen, J., & Jørgensen, T. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1365166 · Cited by 72
Multi-omics profiling: the way toward precision medicine in metabolic diseases
Hu, C., & Jia, W. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab051 · Cited by 118
“Results showed that the two most inclusive GRS were significantly associated with increased fasting plasma glucose and increased incidence of impaired fasting Advanced nextgeneration sequencing GWAS Meta analyses from multiple GWAS and GRS Linkage analyses and candidate approaches MGWAS Pharmacogenomics Metformin Sulf…”
BackgroundInfluentialPhillips, C. M., Goumidi, L., Bertrais, S., Field, M. R., McManus, R., Herçberg, S., Lairon, D., Planells, R., & Roche, H. M. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.11.020 · Cited by 84
“Two genome-wide association studies recently identified novel single nucleotide polymorphisms (SNPs) in the Wnt signalling regulated transcription factor 7-like 2 (TCF7L2) gene which are associated with increased T2DM risk [2,3], most likely through defective beta-cell function and impaired insulin secretion [2].”
BackgroundEsserlind, A.-L., Christensen, A. F., Han, L., Kirchmann, M., Hauge, A. W., Toyserkani, N. M., Hansen, T. F., Grarup, N., Werge, T. M., Steinberg, S., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12055 · Cited by 74
“P-values were adjusted for relatedness by dividing the chi-square statistics by an estimated inflation factor calculated using gene-drop simulations as described previously [24].”
MethodMiyake, K., Yang, W., Hara, K., Yasuda, K., Horikawa, Y., Osawa, H., Furuta, H., Ng, M. C. Y., Hirota, Y., Mori, H., et al. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.17 · Cited by 84
The genetics of IgA nephropathy
Beerman, I., Novák, J., Wyatt, R. J., Julian, B. A., & Gharavi, A. G. (2007) · Nature Reviews Nephrology · doi:10.1038/ncpneph0492 · Cited by 74
“used this type of analysis to discover a genetic variant that conferred susceptibility to type 2 diabetes”
Genetic Architecture of Type 2 Diabetes: Recent Progress and Clinical Implications
Grant, R. W., Moore, A. F., & Florez, J. C. (2009) · Diabetes Care · doi:10.2337/dc08-2171 · Cited by 91
Palomera‐Ávalos, V., Griñán‐Ferré, C., Puigoriol‐Illamola, D., Camins, A., Sanfeliu, C., Canudas, A. M., & Pallàs, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9770-0 · Cited by 83
The evolution and expression of virulence
Ebert, D., & Bull, J. J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0012 · Cited by 83
Sanghera, D. K., Nath, S. K., Ortega, L., Gambarelli, M., Kim-Howard, X., Singh, J. R., Ralhan, S. K., Wander, G. S., Mehra, N. K., Mulvihill, J. J., et al. (2008) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2008.00443.x · Cited by 83
Microsatellite Markers for Linkage and Association Studies
Gulcher, J. R. (2012) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top068510 · Cited by 86
Self-citationWnt modulators in the biotech pipeline
Rey, J., & Ellies, D. L. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22181 · Cited by 71
The role of sulfonylureas in the treatment of type 2 diabetes
Tomlinson, B., Patil, N. G., Fok, M., Chan, P., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1999413 · Cited by 79
Casting a wider net for diabetes susceptibility genes
McCarthy, M. I. (2008) · Nature Genetics · doi:10.1038/ng0908-1039 · Cited by 82
Single Nucleotide Polymorphisms of TCF7L2 Are Linked to Diabetic Coronary Atherosclerosis
Muendlein, A., Saely, C. H., Geller-Rhomberg, S., Sonderegger, G., Rein, P., Winder, T. L., Beer, S., Vonbank, A., & Drexel, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017978 · Cited by 79
“3, has been identified as a major T2DM susceptibility gene [6].”
BackgroundResultA Genome-Wide Association Study Confirms Previously Reported Loci for Type 2 Diabetes in Han Chinese
Cui, B., Zhu, X., Xu, M., Guo, T., Zhu, D., Chen, G., Li, X., Xu, L., Bi, Y., Chen, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022353 · Cited by 87
“Before the year 2007, studies based on linkage analysis and candidate gene strategy identified only a few genetic loci of T2D [5–7].”
BackgroundBrito, E. C., Lyssenko, V., Renström, F., Berglund, G. L., Nilsson, P. M., Groop, L., & Franks, P. W. (2009) · Diabetes · doi:10.2337/db08-1623 · Cited by 89
“ecent advances in highthroughput genotyping methods have facilitated the discovery and confirmation (1-7) of multiple common genetic risk factors for type 2 diabetes.”
BackgroundChong, Z. Z., Shang, Y. C., Hou, J., & Maiese, K. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.2.11758 · Cited by 72
Systolic Blood Pressure and Risk of Type 2 Diabetes: A Mendelian Randomization Study
Aikens, R. C., Zhao, W., Saleheen, D., Reilly, M. P., Epstein, S. E., Tikkanen, E., Salomaa, V., & Voight, B. F. (2017) · Diabetes · doi:10.2337/db16-0868 · Cited by 74
Self-citationAnalysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects
Field, S. F., Howson, J. M. M., Smyth, D. J., Walker, N. M., Dunger, D. B., & Todd, J. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0506-y · Cited by 71
“Until very recently [2] this has not been possible, as no such locus has emerged from type 2 diabetes genetics studies.”
BackgroundInfluentialLara‐Riegos, J., Ortiz‐López, M. G., Peña‐Espinoza, B. I., Montúfar‐Robles, I., Peña-Rico, M. Á., Sanchez-Pozos, K. A., Granados‐Silvestre, M. D. L. Á., & Menjívar, M. (2015) · Gene · doi:10.1016/j.gene.2015.03.065 · Cited by 84
“TCF7L2 is a transcription factor, the most replicated and strongly associated with T2D as well as with impaired insulin secretion (Grant et al., 2006; Weedon, 2007).”
Background
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.